A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Chronic Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
- Status
- RECRUITING
- Phase
- NA
A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
- Status
- RECRUITING
- Phase
- N/A
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Status
- RECRUITING
- Phase
- PHASE2
Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
Upfront Ruxolitinib for Chronic Graft-vs-host Disease
- Status
- TERMINATED
- Phase
- PHASE1
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies
- Status
- COMPLETED
- Phase
- PHASE4
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
- Status
- RECRUITING
- Phase
- PHASE2
Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)
- Status
- RECRUITING
- Phase
- NA
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
- Status
- RECRUITING
- Phase
- PHASE2
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
- Status
- SUSPENDED
- Phase
- PHASE1